Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D2013
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 1,272 $10,509,126 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $10,509,126 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling 1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award SPE2DR25D2013 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance from September 1, 2025 through December 31, 2036 and aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast Guard, and U.S. Naval Fleet. The contract covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The procurement utilizes a Lowest Price Technically Acceptable (LPTA) evaluation methodology, with the intent to make multiple regional awards to at least three different contractors to enhance resiliency and access to vital pharmaceuticals during contingencies or natural disasters.
The original solicitation, expected to be issued in March 2024, will have a 45-day open period and does not include any set-aside requirements, indicating full and open competition. The contract aims to establish a streamlined, comprehensive contracting mechanism to efficiently procure essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries globally.
Task orders
Show 40 more
Latest 50 of 1,272 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D2013?
SPE2DR25D2013 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D2013 worth?
Orders under SPE2DR25D2013 have obligated $10,509,126. SPE2DR25D2013's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D2013?
1,272 orders have been placed under SPE2DR25D2013, the latest on July 29, 2026.
Who can order from contract SPE2DR25D2013?
SPE2DR25D2013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D2013 competed?
The extent of competition for SPE2DR25D2013 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV